Bausch Health Companies INC Form 4 insider transactions

Bausch Health Companies Inc. Director Amy Wechsler acquired 989 common shares as restricted share units for board service, increasing her total beneficial ownership to 266,441 shares.

Paulson & Co. Inc., a 10% owner and director, reported a planned acquisition of 2.5 million shares of Bausch Health Companies Inc. common stock for $6.25 per share under a Rule 10b5-1 plan.

John Paulson amended a Form 4 filing for Bausch Health Companies Inc. to correct an administrative error regarding his indirect beneficial ownership of 70,755,869 common shares.

Bausch Health Companies Inc. director John Paulson acquired 9,689 common shares as Restricted Share Units for his board service, increasing his direct beneficial ownership.

Bausch Health Companies Inc. Director Sandra Leung acquired 3,673 common shares through Restricted Share Units as compensation, increasing her direct beneficial ownership to 33,822 shares.

Bausch Health Companies Inc. director Amy B Wechsler received 1,065 restricted share units as compensation for her board service.

Bausch Health Companies Inc.'s EVP and General Counsel, Seana Carson, reported the sale of common shares totaling 13,370 units under a pre-arranged 10b5-1 trading plan, alongside tax-related share withholding.

Bausch Health Companies Inc. Director Frank D. Lee sold 15,912 common shares to cover tax obligations from a previously vested equity award.

John Paulson, a director and 10% owner of Bausch Health Companies Inc., acquired over 34 million shares of common stock through managed funds.

John Paulson, a director and 10% owner of Bausch Health Companies Inc., significantly increased his indirect beneficial ownership of common stock through recent purchases.

Bausch Health Companies Inc. Director Michael Goettler was granted 30,149 restricted share units, which will vest before the 2026 Annual Meeting of Shareholders.

Bausch Health Companies Inc. Director Sandra Leung was granted 30,149 Restricted Share Units, vesting before the 2026 Annual Meeting of Shareholders.

Bausch Health Companies Inc. EVP, US Pharma, Aimee J. Lenar, was granted 30,847 restricted share units (RSUs) on July 17, 2025, as part of her compensation.

A Bausch Health Companies Inc. executive, Aimee J. Lenar, reported a disposition of 22,736 common shares at $6.42 per share to satisfy tax withholding obligations upon the vesting of Restricted Share Units.

Bausch Health Companies Inc. SVP, Controller & CAO Steven Hyosig Lee was awarded 27,371 restricted share units, aligning executive incentives with long-term company performance.

Bausch Health Companies Inc. Director John Paulson acquired 9,384 common shares through Restricted Share Units as compensation for his board service, increasing his direct beneficial ownership.

Bausch Health Companies Inc. Director Brett Icahn was granted 4,034 Restricted Share Units as compensation for his board service for the quarter ending June 30, 2025.

Bausch Health Companies Inc. Director Amy B. Wechsler acquired 1,032 common shares as Restricted Share Units in lieu of cash compensation for her board service.

John Paulson, a Director and 10% owner of Bausch Health Companies Inc., has significantly increased his indirect beneficial ownership in the company through a purchase of over 3.5 million shares.

Bausch Health Companies Inc. Director and 10% owner John Paulson, through managed funds, has significantly increased his indirect beneficial ownership in the company by acquiring over 2.7 million shares across three transactions in June 2025.

Director Christian A. Garcia receives 54,347 restricted share units (RSUs) from Bausch Health Companies Inc. and disposes of 89,707 common shares.

Director Brett Icahn reports acquiring 54,347 common shares and disposing of 216,246 common shares of Bausch Health Companies Inc. on May 16, 2025.

Director Sarah B. Kavanagh reports acquisition and disposal of Bausch Health Companies Inc. shares related to restricted share units.

Director Frank D. Lee acquired 54,347 common shares of Bausch Health Companies Inc. through a restricted share unit (RSU) grant on May 16, 2025.

Director Steven Miller reports acquisition of restricted share units and disposal of common shares.

Director Richard Mulligan reports acquisition of 54,347 common shares and disposal of 155,616 common shares of Bausch Health Companies Inc.

Director John Paulson reports acquiring shares through restricted share units (RSUs) and disposing of shares, resulting in a change in beneficial ownership.

Director Robert Power acquired 54,347 common shares of Bausch Health Companies Inc. through a restricted share unit (RSU) grant.

Director Amy Wechsler reports acquisition of shares through restricted share units (RSUs) and disposal of shares.

Director Amy Wechsler acquired 1,062 common shares of Bausch Health Companies Inc. in lieu of cash compensation for board service.